To mark the release of his book, Meat, GFI founder Bruce Friedrich talks alternative proteins, political bans, investment struggles, blended meat, cars, and the internet.
Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company. See why PHAR stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results